The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Inhibition of Transforming Growth Factor-β Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice
Abstract
Atherosclerosis is a disease of the arterial wall that seems to be tightly modulated by the local inflammatory balance. Whereas a large body of evidence supports a role for proinflammatory mediators in disease progression, the understanding of the role of the antiinflammatory component in the modulation of plaque progression is only at its beginning. TGF-β1, -β2, and -β3 are cytokines/growth factors with broad activities on cells and tissues in the cardiovascular system and have been proposed to play a role in the pathogenesis of atherosclerosis. However, no study has examined the direct role of TGF-β in the development and composition of advanced atherosclerotic lesions. In the present study, we show that inhibition of TGF-β signaling using a neutralizing anti–TGF-β1, -β2, and -β3 antibody accelerates the development of atherosclerotic lesions in apoE-deficient mice. Moreover, inhibition of TGF-β signaling favors the development of lesions with increased inflammatory component and decreased collagen content. These results identify a major protective role for TGF-β in atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Protective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 831
Self-citationMechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.
Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q. W., & Nathan, C. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.605 · Cited by 655
Lee, R. T., & Libby, P. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1859 · Cited by 558
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Interleukin-10 Blocks Atherosclerotic Events In Vitro and In Vivo
Pinderski Oslund, L. J., Hedrick, C. C., Olvera, T., Hagenbaugh, A., Territo, M., Berliner, J. A., & Fyfe, A. I. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.2847 · Cited by 396
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 378
Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M., & Metcalfe, J. C. (1994) · Nature · doi:10.1038/370460a0 · Cited by 352
Erren, M., Reinecke, H., Junker, R., Fobker, M., Schulte, H., Schurek, J. O., Kropf, J., Kerber, S., Breithardt, G., Assmann, G., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2355 · Cited by 306
Yokota, M., Ichihara, S., Lin, T.-L., Nakashima, N., & Yamada, Y. (2000) · Circulation · doi:10.1161/01.cir.101.24.2783 · Cited by 299
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
Lutgens, E., Cleutjens, K. B. J. M., Heeneman, S., Koteliansky, V. E., Burkly, L. C., & Daemen, M. J. A. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7464 · Cited by 271
Mallat, Z., Heymes, C., Ohan, J., Faggin, E., Lesèche, G., & Tedgui, A. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.611 · Cited by 267
Self-citationTransforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.
Kulkarni, A. B., Ward, J. M., Yaswen, L. R., Mackall, C. L., Bauer, S. R., Huh, C.-G., Gress, R. E., & Karlsson, S. (1995) · PubMed · Cited by 166
McCaffrey, T. A., Du, B., Consigli, S., Szabo, P., Bray, P. J., Hartner, L., Weksler, B. B., Sanborn, T. A., Bergman, G., & Bush, H. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119754 · Cited by 166
Lucas, C., Bald, L. N., Fendly, B. M., Mora-Worms, M., Figari, I. S., Patzer, E. J., & Palladino, M. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.5.1415 · Cited by 164
Smith, W. B., Noack, L., Khew-Goodall, Y., Isenmann, S., Vadas, M. A., & Gamble, J. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.360 · Cited by 162
Bobik, A., Agrotis, A., Kanellakis, P., Dilley, R. J., Krushinsky, A. V., Smirnov, V. N., Tararak, E. M., Condron, M. M., & Kostolias, G. (1999) · Circulation · doi:10.1161/01.cir.99.22.2883 · Cited by 157
Pollman, M. J., Naumovski, L., & Gibbons, G. H. (1999) · Circulation · doi:10.1161/01.cir.99.15.2019 · Cited by 152
Grainger, D. J., Witchell, C., & Metcalfe, J. C. (1995) · Nature Medicine · doi:10.1038/nm1095-1067 · Cited by 136
TGF-βs and TGF-β receptors in atherosclerosis
McCaffrey, T. A. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00034-9 · Cited by 124
Circulating transforming growth factor β1 and coronary artery disease
Wang, X., Liu, S. X., & Wilcken, D. E. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00033-3 · Cited by 100
DiChiara, M. R., Kíely, J.-M., Gimbrone, M. A., Lee, M.-E., Perrella, M. A., & Topper, J. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.695 · Cited by 98
Grainger, D. J., Mosedale, D. E., Metcalfe, J. C., & Böttinger, E. P. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.13.2355 · Cited by 95
Serum levels of the TGF-beta receptor are increased in atherosclerosis
Blann, A. D., Wang, J. M., Wilson, P. B., & Kumar, S. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05713-7 · Cited by 76
Park, S.-K., Yang, W. S., Lee, S. K., Ahn, H., Park, J. S., Hwang, O., & Lee, J. D. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.5.596 · Cited by 67
A PIVOTAL ROLE FOR TGF‐β* IN ATHEROGENESIS?
Grainger, D. J., & Metcalfe, J. C. (1995) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.1995.tb01652.x · Cited by 51
TGF-β in the Cardiovascular System
Topper, J. N. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00061-x · Cited by 48
TGF-β and Endothelial Cells Inhibit VCAM-1 Expression on Human Vascular Smooth Muscle Cells
Gamble, J. R., Bradley, S., Noack, L., & Vadas, M. A. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.949 · Cited by 46
A novel, sensitive bioassay for transforming growth factor β
Randall, L. A., Wadhwa, M., Thorpe, R., & Mire‐Sluis, A. R. (1993) · Journal of Immunological Methods · doi:10.1016/0022-1759(93)90276-d · Cited by 31
Cited by
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004) · Physiological Reviews · doi:10.1152/physrev.00041.2003 · Cited by 3,471
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
the CARDIoGRAMplusC4D Consortium (2015) · Nature Genetics · doi:10.1038/ng.3396 · Cited by 2,447
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Self-citation
Metadata
- Authors
- Mallat, Z., Gojova, A., Marchiol-Fournigault, C., Esposito, B., Kamaté, C., Merval, R., Fradelizi, D., & Tedgui, A.
- Venue
- Circulation Research
- Published
- 2001-11-09
- Volume
- 89
- Issue
- 10
- Pages
- 930-934
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W1979358608
- Cited by
- 490
- References
- 32
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.